TearSolutions Inc. Email Format

Pharmaceutical ManufacturingVirginia, United States2-10 Employees

TearSolutions Inc. is a clinical-stage biotechnology company focused on developing ophthalmic therapeutics. Its leading candidate, Lacripep, is a synthetic peptide derived from lacritin that aims to support wound healing and reinnervation of the corneal epithelium, with the goal of restoring basal tear secretion and overall ocular surface health. The company targets conditions related to ocular surface disease by addressing nerve damage and tear production, offering a potential treatment that combines neurotrophic and prosecretory effects.
Based in Charlottesville, Virginia, TearSolutions operates within the pharmaceutical manufacturing sector and leverages academic-origin research to advance its therapies. The organization appears positioned as a specialized player in ocular biotechnology, progressing through preclinical and early-stage studies to translate its scientific findings into clinically relevant ophthalmic treatments.

Sign up for free to view info

Company overview Employee directory